Wall Street Zen Upgrades 23andMe (OTCMKTS:MEHCQ) to Hold

23andMe (OTCMKTS:MEHCQ) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday.

23andMe Stock Performance

MEHCQ opened at $4.00 on Friday.

23andMe Company Profile

23andMe Inc is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc, formerly known as VG Acquisition Corp., is headquartered in Sunnyvale, CA.